MarketsStocksCHOKSILA
CH

Choksi Laboratories Ltd

NSE: CHOKSILABSE: 526546Healthcare
Download Research Report7-page PDF
119.20
-3.05%
NSE · auto-updates while market open
Mkt Cap
₹79 Cr
P / E
40.3
P / B
3.1
ROE
8.0%
52W High
₹236.70
52W Low
₹81.85
Key Metrics
Market Cap
₹79 Cr
P / E
40.28
P / B
3.09
EV / EBITDA
8.97
ROCE
11.2%
ROE
8.0%
Debt / Equity
1.18
Book Value
₹36.72
EPS
₹2.82
Div Yield
0.0%
Face Value
-
Promoter Holding
31.5%
Revenue · ₹ Cr
28
FY20
26
FY21
30
FY22
34
FY23
37
FY24
42
FY25
46
FY26
Net Profit · ₹ Cr
0
3
1
2
2
-4
-3
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.3
₹4.6
₹1.6
₹2.2
₹2.8
₹-5.6
₹-3.7
FY20FY21FY22FY23FY24FY25FY26
Q1 2026 snapshot
Sales
₹13 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹1.47
Scorecard · 7 axes
Quality
Good
64/100
Valuation
Weak
40.3×
Growth
Strong
+43.4%
Profitability
Weak
9.6%
Performance
Bad
-10.0%
Entry Point
Strong
50%
Red Flags
Strong
0 flags
Shareholding Pattern
31.5%Promoter
Promoter31.5%
FII6.0%
Public62.5%
Quarterly Results · ₹ Cr
QuarterFY17 12QFY18 03QFY18 09Q
Revenue87.69127.118,46,160
Net Profit7.717.9427,930
NPM %8.8%6.2%3.3%
AlertPre-trade